期刊文献+

粘细菌AHB103-1代谢产物抗肿瘤活性的初步研究

Elementary Study on the Antitumor Characteristic of the Metabolite Produced by Myxobacteria AHB 103-1
下载PDF
导出
摘要 本文对粘细菌AHB103-1的次级代谢产物A组分的抗肿瘤活性和作用机制进行了初步的探讨。采用MTT方法研究了它对HepG2、MDA-MB-231、293T和B16四种肿瘤细胞的作用浓度和作用时间,并与临床上应用的几种抗肿瘤药物对HepG2细胞的作用效果进行了比较;利用荧光显微镜和扫描电镜观察研究了它对HepG2细胞的作用机制。结果表明:A组分的抗癌活性比泰素低,却高于表柔比星、依立替康和奥沙利铂。当样品浓度≥15μg/mL时,对各种肿瘤细胞株的抑制率均达到90%以上。随着样品浓度的降低,对各细胞株的抑制率均表现下降趋势。当样品浓度为30μg/mL时,对四种细胞株作用时间选择24 h即有理想效果。当样品浓度为1.88μg/mL时,对B16、293T和HepG2细胞,作用时间选择48 h较好;而对MDA-MB-231,作用时间选择72 h较好。荧光显微镜和扫描电镜观察的结果分别从形态学上证明了A组分具有引起HepG2细胞凋亡的活性。 The antitumor activity and mechanism of component A produced by myxobacteria AHB103-1 were elementarily discussed in the article,. The MTT method was adapted to study the concentration and the action time of the component A for four tumour cell HepG2, MDA-MB-231,293T and B16, and the effect on HepG2 between it and some clinical drugs was compared,. The fluorescence microscope and electron microscope were utilized to study its action mechanism on HepG2 , The results showed that the metabolite' s antitumor activity was lower than paelitaxel, but higher than epirubiein,irinoteean, and oxaliplatin,. More than 90% of inhibition rate for four tumor cell was reached when the sample concentration ≥ 15 μg/mL,. However,the inhibition rate fell with the decreasing of the sample concentration,. On the other hand,the ideal results could be gotten with the handling time for four tumour cell chosen 24 h, when the sample concentration was 30μg/mL,. However, when the sample concentration was 1.88 μg/mL, the suitable handling time should be chosen 48 h for B16,293T and HepG2,but 72 h for MDA-MB-231,. Finally,the observation results by fluorescence microscope and electron microscope respectively proved from morphology the apoptosis of HepG2 induced by the component A.
作者 徐凤 陶文沂
出处 《天然产物研究与开发》 CAS CSCD 2011年第5期833-836,841,共5页 Natural Product Research and Development
基金 国家863计划(2007AA021501)
关键词 次级代谢产物 抗肿瘤活性 抑制率 细胞凋亡 secondary metabolite antitumor activity inhibition rate cell apoptosis
  • 相关文献

参考文献8

  • 1Reichenbach H,Gerth K,Irschik H,et al.Myxobacteria:A source of new antibiotics.Trends Biotechnol,1988,6:115-121.
  • 2Bollag DM,Mcqueney PA,Zhu J,et al.Epothilones,a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.Cancer Res,1995,55:2325-2333.
  • 3Gerth K,Bedorf N,Hofle G,et al.Epothilones A and B:Antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria).J Antibiot,1996,49:560-563.
  • 4张炜.白花蛇舌草对肿瘤细胞信号传导通路的抑制[J].食品与生物技术学报,2006,25(1):50-53. 被引量:23
  • 5Cheng BL(程宝鸾).Techniques for Animal Cell Culture(动物细胞培养技术).Guangzhou:South China University of Technology Press,2000.148.
  • 6Iwamoto Y,Matsumoto Y,Ueoka R.Induction of apoptosis of human ling carcinoma cells by hybrid liposomes containing polyoxyethyenedodecyl ether.Int J Pharm,2005,292:231-239.
  • 7韦玮,郭荣平,李锦清,徐立,张亚奇.不同序贯的西妥昔单抗与化疗药物联合对HepG2和Bel-7402细胞的增殖抑制作用[J].中山大学学报(医学科学版),2008,29(5):556-561. 被引量:9
  • 8Ikeda K,Nagase H.Magnolo has the ability to induce apoptosis in tumor cells.Biol Pharm Bull,2002,25:1546-1549.

二级参考文献23

  • 1谭宁华,王双明,杨亚滨,田芳.白花蛇舌草的抗肿瘤活性和初步化学研究[J].天然产物研究与开发,2002,14(5):33-36. 被引量:57
  • 2董伦,浦佩玉,王虎,康春生,王广秀.胶质瘤中EGFR扩增、过表达及其与肿瘤增殖关系的研究[J].中华神经医学杂志,2005,4(12):1204-1207. 被引量:8
  • 3徐立,张昌卿,冯凯涛,李锦清.肝细胞癌及癌旁肝组织EGFR和EGFR vⅢ的表达及其临床意义[J].中山大学学报(医学科学版),2006,27(4):467-471. 被引量:14
  • 4江苏新医学院.中药大辞典上册[M].上海:上海科学技术出版社,1995.754.
  • 5Lee A V,Schiff R,Cui X J,et al.New mechanisms of signal transduction inhibitor action:receptor tyrosine kinase down-regulation and blockade of signal transactivation[J].Clin Cancer Res,2003,9:516s-523s.
  • 6Zwick E,Bange J,Ullrich A.Receptor tyrosine kinase signaling as a target for cancer intervention strategies[J].Endocr Relat Cancer,2001,8:161-173.
  • 7Yarden Y,Sliwkowski M X.Untangling the ErbB signaling network[J].Nat Rev Mol Cell Biol,2001,2:127-137.
  • 8Becker J.Signal transduction inhibitors-a work in progress[J].Nat Biotech,2004,22:15-18.
  • 9Thomas MB, O' Beirne JP, Furuse J, et al. Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy [J]. Ann Surg Oncol, 2008,15(4) : 1008-1014.
  • 10Laskin J J, Sandier AB. Epidermal growth factor receptor: a promising target in solid tumors [J]. Cancer Treat Rev, 2004,30( 1 ) : 1-17.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部